Bank Of America Corp Exagen Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Exagen Inc. stock. As of the latest transaction made, Bank Of America Corp holds 6,089 shares of XGN stock, worth $21,615. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,089
Previous 6,233
2.31%
Holding current value
$21,615
Previous $19,000
26.32%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding XGN
# of Institutions
43Shares Held
6.05MCall Options Held
1.1KPut Options Held
6.4K-
Rtw Investments, LP New York, NY1.51MShares$5.37 Million0.1% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6891KShares$3.16 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY535KShares$1.9 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA491KShares$1.74 Million0.0% of portfolio
-
Morgan Stanley New York, NY484KShares$1.72 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $57.7M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...